Arrowstreet Capital
TARO

Arrowstreet Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Arrowstreet Capital’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58,888
Closed -$2.49M – 1837
2024
Q1 		$2.49M Buy
58,888
+19,332
+49% +$814K ﹤0.01% 1082
2023
Q4 		$1.65M Sell
39,556
-31,314
-44% -$1.15M ﹤0.01% 999
2023
Q3 		$2.67M Buy
+70,870
New +$2.66M ﹤0.01% 784
2021
Q3 		– Sell
-4,328
Closed -$311K – 1927
2021
Q2 		$311K Buy
+4,328
New +$318K ﹤0.01% 1741
2020
Q4 		– Sell
-23,607
Closed -$1.29M – 2593
2020
Q3 		$1.29M Sell
23,607
-16,583
-41% -$1.03M ﹤0.01% 1740
2020
Q2 		$2.67M Buy
40,190
+36,190
+905% +$2.43M ﹤0.01% 1340
2020
Q1 		$245K Sell
4,000
-50,506
-93% -$3.74M ﹤0.01% 1684
2019
Q4 		$4.79M Sell
54,506
-83,393
-60% -$7.03M 0.01% 870
2019
Q3 		$10.4M Sell
137,899
-13,980
-9% -$1.13M 0.02% 482
2019
Q2 		$13M Sell
151,879
-15,063
-9% -$1.49M 0.03% 430
2019
Q1 		$18M Sell
166,942
-24,266
-13% -$2.42M 0.04% 394
2018
Q4 		$16.2M Sell
191,208
-15,339
-7% -$1.48M 0.04% 331
2018
Q3 		$20.3M Sell
206,547
-4,700
-2% -$509K 0.05% 290
2018
Q2 		$24.4M Buy
211,247
+185,156
+710% +$20.3M 0.06% 271
2018
Q1 		$2.58M Sell
26,091
-79,850
-75% -$8.09M 0.01% 703
2017
Q4 		$11.1M Buy
+105,941
New +$11.6M 0.03% 422
2016
Q2 		– Sell
-8,137
Closed -$1.17M – 1545
2016
Q1 		$1.17M Sell
8,137
-50,652
-86% -$7.19M ﹤0.01% 933
2015
Q4 		$9.08M Buy
58,789
+47,338
+413% +$6.91M 0.04% 376
2015
Q3 		$1.63M Buy
11,451
+221
+2% +$30.9K 0.01% 798
2015
Q2 		$1.61M Buy
+11,230
New +$1.6M 0.01% 690

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Arrowstreet Capital's TARO Position: Q2 2024 in Review

Arrowstreet Capital sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 58,888 shares — an estimated $2.49M sold.

Arrowstreet Capital first reported a position in TARO in Q2 2015 and held it in 20 quarters. The position peaked at $24.4M in Q2 2018. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Arrowstreet Capital reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Arrowstreet Capital sold 58,888 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $2.49M.
  • Arrowstreet Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 20 quarters.
  • Arrowstreet Capital's Taro Pharmaceutical Industries Ltd. position peaked at $24.4M in Q2 2018.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Arrowstreet Capital's 13F filing for Q2 2024, filed 14 Aug 2024.